Risk Stratification of Metabolic Risk Factors and Statin Use Associated With Liver and Nonliver Outcomes in Chronic Hepatitis B
Higher metabolic burden was associated with a greater risk for liver and nonliver complications in patients with CHB, with DM having the highest impact among other MRFs. Statin use was associated with a reduced risk of liver outcomes among lower metabolic burden.
Authors
- Ramsey Cheung (ORCID: https://orcid.org/0000-0002-0211-7013)
- Leslie Y. Kam (ORCID: https://orcid.org/0000-0002-0469-4543)
- Mindie H. Nguyen (ORCID: https://orcid.org/0000-0002-6275-4989)
- Vy H. Nguyen (ORCID: https://orcid.org/0000-0002-9888-8321)
- Scott D. Barnett (ORCID: https://orcid.org/0000-0002-4690-3278)
- Linda Henry
- Xinrong Zhang (ORCID: https://orcid.org/0000-0002-8393-8904)
Institutions
- Harvard University (US)
- Palo Alto University (US)
- VA Palo Alto Health Care System (US)
- Stanford Health Care (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1093/infdis/jiae522
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00